Injection Pen Market: Growth, Size, Share, and Trends

Report Code MD 6041
Published in Aug, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Injection Pen Market Size, Share & Trends by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

Overview

The global injection pen market growth forecasted to transform from USD 47.0 billion in 2024 to USD 74.1 billion by 2030, driven by a CAGR of 7.9%. The surging cases of chronic diseases globally, the launch and approval of new, advanced products, the growing trend towards smart devices, and favorable developments in government policies to promote low-cost injections will stimulate market growth. Much of the demand for injection pens is due to population aging, which has resulted in a greater patient pool for diabetes, obesity, and hormone disorders. Patients have also begun to prefer home-based care, while supportive reimbursement policies and infrastructural development have increased access to injection pens. Thus, the market is projected to see sustained growth in the coming years.

Attractive Opportunities in the Injection Pen Market

North America

Market growth in North America can be attributed to rising patient pool with chronic diseases such as diabetes, obesity, favorable reimbursement policy, large presence of potential companies.

The growth of this market can be attributed to the increasing prevalence of chronic disease, technological advancements, new product launches, and emphasis on patient compliance.

Increased preference of self administration and home care, rising focus on patient centric design and connected device and opportunities in emerging economies are likely to promote significant growth opportunity of the market

North America dominates the hemodialysis and peritoneal dialysis market. This market is projected to reach USD 33.9 billion by 2030, at a CAGR of 7.1% during the forecast period.

Asia Pacific is the fastest-growing regional market for injection pen products, with China and India emerging as major growth hotspots.

Global Injection Pen Market Dynamics

DRIVER: Surge in chronic disease prevalence

The rising cases of chronic conditions are predicted to stimulate the market for injection pens worldwide. Chronic diseases are becoming widely prevalent given an aging patient pool, as confirmed by the increasing cases of obesity and diabetes. The National Diabetes Statistics Report 2022 states that the number of diabetes patients in the US is about 37.3 million persons, or 11.3% of the total population (Source: CDC, 2022). Furthermore, a Novo Nordisk annual report estimated that, by 2030, over 310 million children and adults around the world will be overweight. These factors will bolster the demand for advanced drug delivery systems, including injection pens.

RESTRAINT: Stringent regulatory requirements

The US Food and Drug Administration and other regulatory bodies have specific provisions for pen injector design. Companies are required to follow these prescribed standards. Rigorous testing is necessary to demonstrate that the delivered dose matches the required dosage and that multidose injection pens reliably administer the prescribed requirements. It is also vital to run biocompatibility testing on all injector components and the formulation being injected. These challenging requirements can hinder the introduction of new products in the injection pens market.

 

OPPORTUNITY: Rising focus on patient-centric design and connected devices

To improve treatment outcomes and the user experience, connected injection pens need to be developed with consideration for patient-centric design concepts. Features like finer needles and easier injections have been emphasized as companies seek to resolve patient concerns like pain and needle phobia. This aspect of the injection pen market has seen rising interest. For example, Medtronic (Ireland) offers a reusable, Bluetooth-enabled pen, the InPen, which comes with intelligent dosage capabilities for patients on multiple daily injection (MDI) therapy. It can be used in conjunction with a mobile app and is compatible with insulin cartridges from Eli Lilly Humalog, Novo Nordisk Novolog, and Novo Nordisk Fiasp.

CHALLENGE: Lack of training and education

Inadequate education and training on using newer delivery devices, including injection pens, leads to errors and affects the safety of both the staff and patients. The Journal of Diabetes Science and Technology estimates that injection pens are involved in 39% of needlestick injuries (NSIs). Nursing workers were the most affected, with 40.4% reported to experience NSIs. Healthcare workers in the Asia Pacific (APAC) are frequently affected by NSIs resulting from insulin injections.

Global Injection Pen Market Ecosystem Analysis

Disposable injection pens held the largest market share in the global injection pen industry in 2023. Based on type, the disposable injection pens segment held the largest share of the injection pen market. Patients are using disposable injection pens to a greater extent due to their convenience, low risk of needle stick infections, and built-in cartridge that prevents the need for manual loading. This feature is especially beneficial for patients with vision impairments or limited ability. Their advantages have bolstered the adoption of disposable injection pens.

 

Home care settings will grow at a significant rate from 2024 to 2030 in the end-user market in the injection pen industry.

Based on the end user, the injection pen market has been classified into hospitals & clinics and home care settings. The market for injection pens was dominated in 2023 by the home care settings segment. As chronic diseases become more prevalent and the population ages, the increased ease of medication administration, advancements in technology, and favorable reimbursement structures are the main factors contributing to the rapid growth of home care settings in the injection pen market.

 

 

North America region holds the largest share of the Injection Pen Market.

During the forecast period, North America is anticipated to be the largest region in the injection pen market. The injection pen market in North America is projected to increase due to a number of factors, including the availability of favorable reimbursement options, rising public awareness of new injection pen technologies, supportive government initiatives, rising affordability and per capita healthcare expenditure, and the presence of numerous international pharmaceutical giants, including Pfizer (US) and Becton Dickinson and Company (US).

 
 

Recent Developments of Injection Pen Market industry

  • In June 2024, Novo Nordisk A/S (Denmark) launched smart insulin pens in the UK: NovoPen 6 and NovoPen Echo. These pens can track and record dosing information for diabetic patients. In April 2024, Eli Lilly and Company (US) acquired a manufacturing facility from Nexus Pharmaceuticals, LLC, to expand the global parenteral (injectable) product manufacturing network and support the increased demand.
  • In April 2023, Ypsomed Holding AG (Switzerland)) opened a production facility in the Changzhou National Hi-tech District to cater to the rapidly growing Chinese market for injection systems. In the first phase, the company invested over USD 38.9 million (CHF 35 million) in the new manufacturing plant.

Key Market Players

KEY PLAYERS IN THE Injection Pen Market INCLUDE

Want to explore hidden markets that can drive new revenue in Injection Pen Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $47.0 billion
Projected Revenue by 2030 $74.1 billion
Revenue Rate Poised to Grow at a CAGR of 7.9%
Market Driver Surge in chronic disease prevalence
Market Opportunity Rising focus on patient-centric design and connected devices

 

Key Questions Addressed by the Report

What are the drivers for the injection pen market?
The growing prevalence of chronic diseases such as diabetes, a favorable reimbursement scenario, and the focus on developing technologically advanced injection pen products are likely to propel the market growth during the forecast period.
Which therapy segment in the injection pen market provides the most opportunity for growth?
The diabetes segment will show the most opportunity for growth due to the rising prevalence of diabetes, the increasing aged patient pool, government initiatives, and patient awareness, which indicate strong opportunities in this segment.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Injection Pen Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
22
RESEARCH METHODOLOGY
26
EXECUTIVE SUMMARY
41
PREMIUM INSIGHTS
45
MARKET OVERVIEW
48
  • 5.1 MARKET DYNAMICS
    DRIVERS
    - Surge in chronic diseases
    - Favorable reimbursement and government support
    - Emergence of new technologies
    RESTRAINTS
    - Stringent regulatory requirements
    OPPORTUNITIES
    - Rising focus on patient-centric design and connected devices
    - Growth opportunities in emerging economies
    CHALLENGES
    - Lack of training and education
    - Need to minimize side effects and injection-site reactions
  • 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Connectivity and smart features
    - Pen injector materials
    COMPLEMENTARY TECHNOLOGIES
    - In-built functions
    - Wireless connectivity
    - Smart caps and attachments
    ADJACENT TECHNOLOGIES
    - Autoinjectors
    - Insulin pumps
    - Wearable insulin injectors
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.6 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 REGULATORY LANDSCAPE
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR INJECTION PENS
    JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF INSULIN PENS, BY KEY PLAYER
    AVERAGE SELLING PRICE OF GLP-1 PENS, BY KEY PLAYER
    AVERAGE SELLING PRICE, BY THERAPY
    AVERAGE SELLING PRICE, BY REGION
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 REIMBURSEMENT ANALYSIS
  • 5.16 UNMET NEEDS IN INJECTION PEN MARKET
  • 5.17 END-USER EXPECTATIONS IN INJECTION PEN MARKET
  • 5.18 IMPACT OF AI ON INJECTION PEN MARKET
  • 5.19 INVESTMENT AND FUNDING SCENARIO
INJECTION PEN MARKET, BY TYPE
86
  • 6.1 INTRODUCTION
  • 6.2 DISPOSABLE INJECTION PENS
    GROWING GERIATRIC POPULATION TO DRIVE MARKET
  • 6.3 REUSABLE INJECTION PENS
    ONGOING TECHNOLOGICAL ADVANCEMENTS TO FUEL MARKET
INJECTION PEN MARKET, BY THERAPY
94
  • 7.1 INTRODUCTION
  • 7.2 DIABETES
    INSULIN
    - Rising prevalence of diabetes to aid market growth
    GLUCAGON-LIKE PEPTIDE-1
    - Rising focus on research & development to propel market
  • 7.3 GROWTH HORMONE THERAPY
    INCREASED SUPPORT FOR CO-PAYMENT OF DRUG DELIVERY SERVICES TO FUEL MARKET
  • 7.4 OSTEOPOROSIS
    GROWING UPTAKE FOR TREATING BONE ISSUES TO SUPPORT MARKET
  • 7.5 FERTILITY
    CHANGING LIFESTYLE AND RISING INCIDENCE OF IMPOTENCE TO BOOST DEMAND
  • 7.6 OBESITY
    RISING PREVALENCE OF OBESITY IN HIGH-INCOME COUNTRIES TO DRIVE MARKET
  • 7.7 OTHER THERAPIES
INJECTION PEN MARKET, BY END USER
112
  • 8.1 INTRODUCTION
  • 8.2 HOME CARE SETTINGS
    TREND OF SELF-ADMINISTRATION TO STIMULATE GROWTH
  • 8.3 HOSPITALS & CLINICS
    NEEDLESTICK INJURIES AND UNSAFE INJECTION PRACTICES TO PROPEL DEMAND
INJECTION PEN MARKET, BY REGION
117
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    US
    - Increasing prevalence of diabetes and infertility to drive market
    CANADA
    - Booming healthcare expenditure to fuel market
  • 9.3 EUROPE
    GERMANY
    - Advanced healthcare system and insurance coverage to boost market
    FRANCE
    - Growing incidence of chronic diseases to foster growth
    UK
    - Rising focus on educating patients and staff about safe use of injection pens to aid growth
    ITALY
    - Heterogenous reimbursement policies to hinder market growth
    SPAIN
    - Favorable healthcare regulations to aid growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    JAPAN
    - Universal healthcare coverage to fuel market
    CHINA
    - Growing focus on public health services to support market growth
    INDIA
    - Rapid population growth to drive market
    SOUTH KOREA
    - Surge in collaborations among companies to increase adoption of injectables
    AUSTRALIA
    - Increasing regulatory approvals to augment growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    BRAZIL
    - Surge in obesity issues to stimulate market growth
    MEXICO
    - Increasing incidence of chronic diseases to drive growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Growing preference among patients for self-administration to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
166
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INJECTION PEN MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Type footprint
    - Therapy footprint
    - Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
185
  • 11.1 KEY PLAYERS
    NOVO NORDISK A/S
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ELI LILLY AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SANOFI
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    YPSOMED HOLDING AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    ASTRAZENECA
    - Business overview
    - Products offered
    - Recent developments
    OWEN MUMFORD
    - Business overview
    - Products offered
    HASELMEIER
    - Business overview
    - Products offered
    SUN PHARMACEUTICAL INDUSTRIES LTD.
    - Business overview
    - Products offered
    PFIZER INC.
    - Business overview
    - Products offered
    BIOCON
    - Business overview
    - Products offered
    - Recent developments
    LUPIN
    - Business overview
    - Products offered
    WOCKHARDT LTD.
    - Business overview
    - Products offered
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    GERRESHEIMER AG
    SHAILY ENGINEERING PLASTICS LTD.
    SHL MEDICAL AG
    EMPERRA GMBH E-HEALTH TECHNOLOGIES
    NEMERA FRANCE SAS
    JIANGSU DELFU MEDICAL DEVICE CO., LTD.
    SOLTEAM MEDICAL
    PHILLIPS-MEDISIZE - A MOLEX COMPANY
    STEVANATO GROUP
    WANHAI MEDICAL INSTRUMENTS CO., LTD.
APPENDIX
234
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 INJECTION PEN MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 USD CONVERSION RATES, 2021–2023
  • TABLE 3 CLASSIFICATION OF PEN INJECTORS
  • TABLE 4 IMPORT DATA FOR MEDICAMENTS CONTAINING INSULIN IN MEASURED DOSES (HS CODE 300431), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 5 EXPORT DATA FOR MEDICAMENTS CONTAINING INSULIN IN MEASURED DOSES (HS CODE 300431), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 6 INJECTION PEN MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 7 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
  • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
  • TABLE 11 CHINA: REGULATORY BODIES FOR MEDICAL DEVICE APPROVAL
  • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 AVERAGE SELLING PRICE TREND OF INJECTION PENS, BY THERAPY, 2023 (USD)
  • TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTION PENS, BY REGION, 2021–2023 (USD)
  • TABLE 20 KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 22 KEY BUYING CRITERIA, BY END USER
  • TABLE 23 CASE STUDY 1: USE OF UNOPEN INJECTOR PEN FOR ACCURATE DOSAGE OF INSULIN
  • TABLE 24 CASE STUDY 2: ADOPTION OF PEN INJECTOR PLATFORMS FOR IMPROVED THERAPEUTIC OUTCOMES
  • TABLE 25 REIMBURSEMENT CODES
  • TABLE 26 END-USER EXPECTATIONS
  • TABLE 27 INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 28 INJECTION PEN DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 29 DISPOSABLE INJECTION PENS AVAILABLE IN MARKET
  • TABLE 30 INJECTION PEN MARKET FOR DISPOSABLE INJECTION PENS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 31 INJECTION PEN MARKET FOR DISPOSABLE INJECTION PEN DEVICES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 32 REUSABLE INJECTION PENS AVAILABLE IN MARKET
  • TABLE 33 INJECTION PEN MARKET FOR REUSABLE INJECTION PENS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 34 INJECTION PEN MARKET FOR REUSABLE INJECTION PEN DEVICES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 35 INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 36 INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 37 INJECTION PEN MARKET FOR DIABETES THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 38 INJECTION PENS FOR INSULIN AVAILABLE IN MARKET
  • TABLE 39 INJECTION PEN MARKET FOR INSULIN THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 40 INJECTABLE DRUGS FOR GLUCAGON-LIKE PEPTIDE-1 THERAPY IN CLINICAL TRIAL PHASES
  • TABLE 41 INJECTION PEN MARKET FOR GLUCAGON-LIKE PEPTIDE-1 THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 42 INJECTION PENS FOR GROWTH HORMONE THERAPY AVAILABLE IN MARKET
  • TABLE 43 INJECTION PEN MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 44 INJECTION PEN MARKET FOR OSTEOPOROSIS THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 45 INJECTION PEN MARKET FOR FERTILITY THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 46 INJECTION PEN MARKET FOR OBESITY THERAPY, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 47 INJECTION PEN MARKET FOR OTHER THERAPIES, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 48 INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 49 INJECTION PEN MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 50 INJECTION PEN MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 51 INJECTION PEN MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: INJECTION PEN MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 53 NORTH AMERICA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 54 NORTH AMERICA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 55 NORTH AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 57 US: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 58 US: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 59 US: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 60 US: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 61 CANADA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 62 CANADA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 63 CANADA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 64 CANADA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 65 EUROPE: INJECTION PEN MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 66 EUROPE: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 67 EUROPE: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 68 EUROPE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 69 EUROPE: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 70 GERMANY: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 71 GERMANY: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 72 GERMANY: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 73 GERMANY: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 74 FRANCE: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 75 FRANCE: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 76 FRANCE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 77 FRANCE: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 78 UK: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 79 UK: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 80 UK: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 81 UK: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 82 ITALY: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 83 ITALY: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 84 ITALY: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 85 ITALY: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 86 SPAIN: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 87 SPAIN: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 88 SPAIN: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 89 SPAIN: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 90 REST OF EUROPE: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 91 REST OF EUROPE: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 92 REST OF EUROPE: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 93 REST OF EUROPE: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: INJECTION PEN MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 99 JAPAN: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 100 JAPAN: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 101 JAPAN: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 JAPAN: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 103 CHINA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 104 CHINA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 105 CHINA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 106 CHINA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 107 INDIA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 INDIA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 109 INDIA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 110 INDIA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 111 SOUTH KOREA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 112 SOUTH KOREA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 113 SOUTH KOREA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 114 SOUTH KOREA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 115 AUSTRALIA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 116 AUSTRALIA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 117 AUSTRALIA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030(USD MILLION)
  • TABLE 118 AUSTRALIA: INJECTION PEN MARKET, BY END USER, 2022–2030(USD MILLION)
  • TABLE 119 REST OF ASIA PACIFIC: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 REST OF ASIA PACIFIC: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 121 REST OF ASIA PACIFIC: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 122 REST OF ASIA PACIFIC: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 123 LATIN AMERICA: INJECTION PEN MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 125 LATIN AMERICA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 126 LATIN AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 128 BRAZIL: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 BRAZIL: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 130 BRAZIL: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 BRAZIL: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 132 MEXICO: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 133 MEXICO: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 134 MEXICO: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 MEXICO: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 136 REST OF LATIN AMERICA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 137 REST OF LATIN AMERICA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 138 REST OF LATIN AMERICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 REST OF LATIN AMERICA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 140 MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 141 MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 142 MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 144 MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 145 GCC COUNTRIES: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 146 GCC COUNTRIES: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 147 GCC COUNTRIES: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 148 GCC COUNTRIES: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 149 REST OF MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 150 REST OF MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY THERAPY, 2022–2030 (USD MILLION)
  • TABLE 151 REST OF MIDDLE EAST & AFRICA: INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 152 REST OF MIDDLE EAST & AFRICA: INJECTION PEN MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 153 INJECTION PEN MARKET: DEGREE OF COMPETITION
  • TABLE 154 INJECTION PEN MARKET: TYPE FOOTPRINT
  • TABLE 155 INJECTION PEN MARKET: THERAPY FOOTPRINT
  • TABLE 156 INJECTION PEN MARKET: REGION FOOTPRINT
  • TABLE 157 INJECTION PEN MARKET: LIST OF KEY STARTUPS/SMES
  • TABLE 158 INJECTION PEN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 159 INJECTION PEN MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2024
  • TABLE 160 INJECTION PEN MARKET: DEALS, JANUARY 2021–JULY 2024
  • TABLE 161 INJECTION PEN MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
  • TABLE 162 INJECTION PEN MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024
  • TABLE 163 NOVO NORDISK A/S: COMPANY OVERVIEW
  • TABLE 164 NOVO NORDISK A/S: PRODUCTS OFFERED
  • TABLE 165 NOVO NORDISK A/S: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021— JULY 2024
  • TABLE 166 NOVO NORDISK A/S: DEALS, JANUARY 2021— JULY 2024
  • TABLE 167 ELI LILLY AND COMPANY: COMPANY OVERVIEW
  • TABLE 168 ELI LILLY AND COMPANY: PRODUCTS OFFERED
  • TABLE 169 ELI LILLY AND COMPANY: DEALS, JANUARY 2021— JULY 2024
  • TABLE 170 ELI LILLY AND COMPANY: EXPANSIONS, JANUARY 2021— JULY 2024
  • TABLE 171 SANOFI: COMPANY OVERVIEW
  • TABLE 172 SANOFI: PRODUCTS OFFERED
  • TABLE 173 SANOFI: DEALS, JANUARY 2021— JULY 2024
  • TABLE 174 YPSOMED HOLDING AG: COMPANY OVERVIEW
  • TABLE 175 YPSOMED HOLDING AG: PRODUCTS OFFERED
  • TABLE 176 YPSOMED HOLDING AG: EXPANSIONS, JANUARY 2021— JULY 2024
  • TABLE 177 YPSOMED HOLDING AG: OTHER DEVELOPMENTS, JANUARY 2021— JULY 2024
  • TABLE 178 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 179 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 180 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 181 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 182 ASTRAZENECA: COMPANY OVERVIEW
  • TABLE 183 ASTRAZENECA: PRODUCTS OFFERED
  • TABLE 184 ASTRAZENECA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021— JULY 2024
  • TABLE 185 OWEN MUMFORD: COMPANY OVERVIEW
  • TABLE 186 OWEN MUMFORD: PRODUCTS OFFERED
  • TABLE 187 HASELMEIER: COMPANY OVERVIEW
  • TABLE 188 HASELMEIER: PRODUCTS OFFERED
  • TABLE 189 SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY OVERVIEW
  • TABLE 190 SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED
  • TABLE 191 PFIZER INC.: COMPANY OVERVIEW
  • TABLE 192 PFIZER INC.: PRODUCTS OFFERED
  • TABLE 193 BIOCON: COMPANY OVERVIEW
  • TABLE 194 BIOCON: PRODUCTS OFFERED
  • TABLE 195 BIOCON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021— JULY 2024
  • TABLE 196 BIOCON: DEALS, JANUARY 2021— JULY 2024
  • TABLE 197 LUPIN: COMPANY OVERVIEW
  • TABLE 198 LUPIN: PRODUCTS OFFERED
  • TABLE 199 WOCKHARDT LTD.: COMPANY OVERVIEW
  • TABLE 200 WOCKHARDT LTD.: PRODUCTS OFFERED
  • TABLE 201 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 202 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 203 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021— JULY 2024
  • TABLE 204 GERRESHEIMER AG: COMPANY OVERVIEW
  • TABLE 205 SHAILY ENGINEERING PLASTICS LTD.: COMPANY OVERVIEW
  • TABLE 206 SHL MEDICAL AG: COMPANY OVERVIEW
  • TABLE 207 EMPERRA GMBH E-HEALTH TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 208 NEMERA FRANCE SAS: COMPANY OVERVIEW
  • TABLE 209 JIANGSU DELFU MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW
  • TABLE 210 SOLTEAM MEDICAL: COMPANY OVERVIEW
  • TABLE 211 PHILIP-MEDISIZE- A MOLEX COMPANY: COMPANY OVERVIEW
  • TABLE 212 STEVANTO GROUP: COMPANY OVERVIEW
  • TABLE 213 WANHAI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 INJECTION PEN MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 INJECTION PEN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION)
  • FIGURE 5 INJECTION PEN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 MARKET SIZE ESTIMATION BASED ON REVENUE SHARE ANALYSIS
  • FIGURE 8 ILLUSTRATIVE EXAMPLE OF NOVO NORDISK A/S: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 9 MARKET SIZE ESTIMATION FOR INJECTION PEN DEVICES BASED ON REVENUE SHARE ANALYSIS
  • FIGURE 10 ILLUSTRATIVE EXAMPLE OF YPSOMED AG: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 11 INJECTION PEN MARKET: TOP-DOWN APPROACH
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 DATA TRIANGULATION
  • FIGURE 14 INJECTION PEN MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 INJECTION PEN MARKET, BY THERAPY, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 INJECTION PEN MARKET FOR DIABETES THERAPY, BY TYPE, 2024 VS. 2030(USD MILLION)
  • FIGURE 17 INJECTION PEN MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF INJECTION PEN MARKET, 2024–2029
  • FIGURE 19 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • FIGURE 20 DIABETES SEGMENT AND JAPAN ACCOUNTED FOR LARGEST SHARES IN ASIA PACIFIC INJECTION PEN MARKET IN 2023
  • FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 22 DEVELOPING MARKETS TO ACCOUNT FOR HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 23 INJECTION PEN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 PATIENTS WITH CHRONIC DISEASES IN US, 1995–2030 (MILLION)
  • FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2029 VS. 2030 VS. 2040 (MILLION)
  • FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR INJECTION PEN PROVIDERS
  • FIGURE 27 INJECTION PEN MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 INJECTION PEN MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 29 INJECTION PEN MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
  • FIGURE 31 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
  • FIGURE 32 PATENTS GRANTED WORLDWIDE, JANUARY 2014–JUNE 2024
  • FIGURE 33 PATENT ANALYSIS, JANUARY 2014–JUNE 2024
  • FIGURE 34 AVERAGE SELLING PRICE TREND OF INSULIN PENS, BY KEY PLAYER, 2023 (USD)
  • FIGURE 35 AVERAGE SELLING PRICE TREND OF GLP-1 PENS, BY KEY PLAYER, 2023 (USD)
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 37 KEY BUYING CRITERIA, BY END USER
  • FIGURE 38 INJECTION PEN MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 39 INVESTMENT AND FUNDING SCENARIO, 2018–2022
  • FIGURE 40 NORTH AMERICA: INJECTION PEN MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: INJECTION PEN MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN INJECTION PEN MARKET, 2021–2023
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN INJECTION PEN MARKET, 2023
  • FIGURE 44 INJECTION PEN MARKET: COMPANY EVALUATION MATRIX, 2023
  • FIGURE 45 INJECTION PEN MARKET: COMPANY FOOTPRINT
  • FIGURE 46 INJECTION PEN MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 INJECTION PEN MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 50 NOVO NORDISK A/S: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 52 SANOFI: COMPANY SNAPSHOT (2023)
  • FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2023)
  • FIGURE 54 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
  • FIGURE 55 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 56 ASTRAZENECA: COMPANY SNAPSHOT (2023)
  • FIGURE 57 SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 PFIZER INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 BIOCON: COMPANY SNAPSHOT (2023)
  • FIGURE 60 LUPIN: COMPANY SNAPSHOT (2023)
  • FIGURE 61 WOCKHARDT LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 MEDTRONIC: COMPANY SNAPSHOT (2023)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), American Journal of Drug Delivery and Therapeutics, International Diabetes Federation (IDF), American Association of Diabetes Educators (AADE, Asian Association for the Study of Diabetes (AASD) and Parenteral Drug Association (PDA) were referred to identify and collect information for the global injection pen market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the injection pen market. The primary sources from the demand side include hospitals & clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Injection  Pens Market Size, and Share

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global injection pen market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global injection pen  market was split into various segments and sub-segments based on:

  • List of major players operating in the injection pen  products market at the regional and/or country level
  • Product mapping of various injection pen  manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from injection pen(or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

Illustrative example of Novo Nordisk A/S: Revenue Share Analysis, 2023

Injection  Pens Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation

After arriving at the overall size of the global Injection pen market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Injection pens are used by patients or self-administering drugs for the treatment of various diseases such as diabetes, osteoporosis, growth hormone deficiency, obesity, fertility and among others. These medical devices are easy to handle and cost-effective for patients.

Stakeholders

  • Injection Pen Manufacturing Companies
  • Pharmaceutical Companies (Drug Manufacturers)
  • Original Equipment Manufacturing Companies   
  • Suppliers and Distributors of Injection Pens
  • Healthcare Service Providers
  • Teaching Hospitals and Academic Medical Centers
  • Health Insurance Players
  • Government Bodies/Municipal Corporations
  • Regulatory Bodies
  • Medical Research Institutes
  • Business Research and Consulting Service Providers
  • Venture Capitalists
  • Market Research and Consulting Firms

Report Objectives

  • To define, measure, and describe the global injection pen market by type, therapy, end user, and region
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
  • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically analyze the market structure, profile the key players in the global injection pen market, and comprehensively analyze their core competencies
  • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the injection pen market
  • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global injection pen  market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe injection pen market into Russia, Switzerland, Denmark, Austria, and others
  • Further breakdown of the Rest of Asia Pacific injection pen market into South Korea, Taiwan, and others
  • Further breakdown of the Rest of Latin America injection pen market into Argentina, Colombia, Chile, Ecuador, and others
  • Further breakdown of the Southeast Asia injection pen market into Malaysia, Singapore, Australia, New Zealand, and others

Competitive Landscape Assessment

  • Market share analysis, by region (North America and Europe), which provides market shares of the top 3-5 key players in the injection pen market
  • Competitive leadership mapping for established players in the US

Previous Versions of this Report

Injection Pen Market by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2026

Report Code MD 6041
Published in Nov, 2021, By MarketsandMarkets™

Injection Pen Market by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2026

Report Code MD 6041
Published in Feb, 2018, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Injection Pen Market

Dr.

May, 2022

who are the prominent players in diabetes injection pens market. pls share list.

Julie

May, 2022

Need tailor made research report on injection pen market with informative data and various critical aspects such as market outlook, market share, growth, and trends. .

Mark

May, 2022

advancements in injection pen market. how is it going to sustain. details pls.

DMCA.com Protection Status